Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
- PDP - 68071 2308 9
- Figure 1 - image 01
- Figure 2 - image 02
- Figure 3 - image 03
- Cockcroft and Gault Equation - image 04
- Gabapentin Structural Formula - image 05
- Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09
Product Label Images
The following 7 images provide visual information about the product associated with Gabapentin NDC 68071-2308 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PDP - 68071 2308 9
Gabapentin is a medication used to treat seizure disorders and nerve pain. The text is a label of Gabapentin 300mg, with specific details such as Lot number, manufacturer, and expiration date. It also warns to keep the medicine out of reach of children and includes information to call a doctor if side effects occur. The medication should be stored at a controlled temperature of 59-86°F.*
Figure 1 - image 01
This appears to be a table or graph displaying pain scores and treatment options for a certain period of time. It shows different dosages of medication, including Gabapentin at 3600 mg per day, and a placebo option. The table/graph includes a baseline measurement and measures taken over the course of weeks. The main heading seems to be "Mean Pain Score".*
Figure 2 - image 02
This is a chart that shows the results of a study on pain relief medication. It illustrates the mean pain score of a group of patients over a 7-week period, including a 4-week fixed dose period. The study includes a placebo and two doses of Gabapentin - 1800mg/day and 2400mg/day. The X-axis shows the weeks of the study and the Y-axis shows the mean pain score. There is no further information to provide.*
Figure 3 - image 03
Cockcroft and Gault Equation - image 04
Gabapentin Structural Formula - image 05
Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
